Holen Sie sich die Stockscreener-App
9.20
1.21%
0.14
Schlusskurs vom Vortag:
$9.06
Offen:
$9.4708
24-Stunden-Volumen:
4,410
Relative Volume:
0.09
Marktkapitalisierung:
$7.46M
Einnahmen:
$43.86M
Nettoeinkommen (Verlust:
$-37.43M
KGV:
-4.5608
EPS:
-2.0172
Netto-Cashflow:
$-12.50M
1W Leistung:
-4.48%
1M Leistung:
-26.23%
6M Leistung:
-56.39%
1J Leistung:
-72.21%
1-Tages-Spanne:
$8.86
$9.52
1-Wochen-Bereich:
$8.8022
$9.90
52-Wochen-Spanne:
$7.94
$52.50
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Firmenname
Trinity Biotech Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare TRIB vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
9.17 | 7.37M | 43.86M | -37.43M | -12.50M | -2.0172 |
ABT
Abbott Laboratories
|
106.17 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.62 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.14 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.80 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.53 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2015-10-23 | Herabstufung | Craig Hallum | Buy → Hold |
| 2015-09-03 | Eingeleitet | Raymond James | Outperform |
| 2015-07-29 | Bestätigt | ROTH Capital | Buy |
| 2008-07-22 | Bestätigt | Roth Capital | Buy |
| 2008-03-17 | Bestätigt | Roth Capital | Buy |
| 2007-12-10 | Bestätigt | Roth Capital | Buy |
| 2007-10-26 | Bestätigt | Roth Capital | Buy |
Alle ansehen
Trinity Biotech Plc Adr Aktie (TRIB) Neueste Nachrichten
Shareholders of Trinity Biotech (NASDAQ: TRIB) face key 2026 AGM votes - Stock Titan
Trinity Biotech plcADR Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Trinity Biotech expands PrePsia patent portfolio to nine patents - Investing.com
Trinity Biotech secures $7m from Perceptive Advisors - Investing.com
TRINITY BIOTECH PLC-SPON ADR (TRIB) Stock Chart - ChartMill
TRIB,ZBRA Volatility & Greeks - Finviz
Trinity Biotech plc Sponsored ADR Revenue Breakdown – FWB:TRB0 - TradingView
India Hba1c Testing Devices Market Size & Outlook, 2026-2033 - Grand View Research
Trinity Biotech plc (TRIB) stock price, news, quote and history - Yahoo Finance UK
Trinity Biotech partners with Latch Medical on metabolic health tech - Investing.com
These stocks are moving in today's pre-market session - ChartMill
Trinity Biotech plans 1-for-30 reverse ADS split - Investing.com
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change - Yahoo Finance
Price to book forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Enterprise value to EBIT forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Price to earnings forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Price to sales forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Enterprise value to revenue forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Enterprise value to EBITDA forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Trinity Biotech CGM+ detects false low glucose alerts during sleep - Investing.com
TRIBTrinity Biotech Plc ADR Volatility & Greeks - Finviz
Trinity Biotech unit secures OCP membership for AI cooling - Investing.com
Trinity Biotech unit secures OCP membership for AI cooling By Investing.com - Investing.com India
Trinity Biotech Plc Sponsored ADR Class A Actuals & Estimates (NASDAQ:TRIB) - TradingView
The market is filled with gapping stocks in Tuesday's session. - ChartMill
Form 6K Trinity Biotech plc For: 23 June By Investing.com - Investing.com South Africa
Trinity Biotech launches liquid cooling subsidiary Trinovium - Investing.com
Trinity Biotech announces orders for over 2 million HIV tests and Q1 results By Investing.com - Investing.com South Africa
Trinity Biotech announces orders for over 2 million HIV tests and Q1 results - Investing.com
Number of shareholders of Trinity Biotech plc ADR – FWB:TRB0 - TradingView
Trinity Biotech (TRIB) 10K Form and Latest SEC Filings 2026 - MarketBeat
Trinity Biotech names Jerry Lydon head of North America operations - Investing.com
New LowStock ScreenerSnapshot - Finviz
Trinity Biotech plc Stock: Navigating Challenges in the Diagnostics Sector Amid Market Volatility - AD HOC NEWS
Trinity Biotech reports clinical study results for prostate test By Investing.com - Investing.com South Africa
Trinity Biotech reports clinical study results for prostate test - Investing.com
ADR Ratio Change - Yahoo Finance
Trinity Biotech advances CGM+ device toward pivotal trial - Investing.com
Trinity Biotech secures $25M equity financing facility By Investing.com - Investing.com South Africa
Trinity Biotech receives Nasdaq delisting warning notice - Investing.com
Trinity Biotech receives final approval for HIV test manufacturing shift - Investing.com India
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification - Investing.com
Trinity Biotech stock soars after major HIV test order signals market recovery - Investing.com
Trinity Biotech expands rollout of next-gen HbA1c testing system - Investing.com
Trinity Biotech (TRIB) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $TRIB - MarketBeat
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
Trinity Biotech receives approval for offshore manufacturing of HIV test - Investing.com
Should I buy Trinity Biotech (TRIB) - Zacks Investment Research
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test - Investing.com
Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market - Sahm
TRIB: Revenue and margins declined in Q1 2025, but a strong rebound is expected in Q2 - TradingView
Finanzdaten der Trinity Biotech Plc Adr-Aktie (TRIB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):